Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

IMPORTANCE: Immunotherapy with checkpoint inhibitors targeting the PD-1 (programmed cell death 1) axis has brought notable progress in patients with non–small cell lung cancer (NSCLC) and other cancers. However, autoimmune toxic effects are frequent and poorly understood, making it important to unde...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Berner, Fiamma, Bomze, David, Diem, Stefan, Ali, Omar Hasan, Fässler, Mirjam, Ring, Sandra, Niederer, Rebekka, Ackermann, Christoph J., Baumgaertner, Petra, Pikor, Natalia, Cruz, Cristina Gil, van de Veen, Willem, Akdis, Mübeccel, Nikolaev, Sergey, Läubli, Heinz, Zippelius, Alfred, Hartmann, Fabienne, Cheng, Hung-Wei, Hönger, Gideon, Recher, Mike, Goldman, Jonathan, Cozzio, Antonio, Früh, Martin, Neefjes, Jacques, Driessen, Christoph, Ludewig, Burkhard, Hegazy, Ahmed N., Jochum, Wolfram, Speiser, Daniel E., Flatz, Lukas
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487908/
https://ncbi.nlm.nih.gov/pubmed/31021392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.0402
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados